During the past decade, Baptist Cardiac and Vascular Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 20 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Cardiac and Vascular Institute" #1 sponsor was "Baptist Health South Florida" with 4 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "Endologix" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Bolton Medical" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Cardiac and Vascular Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "BSN Medical Inc" with 1 trials as a collaborator and "Biosense Webster, Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Cardiac and Vascular Institute" are "Atherosclerosis" (3 trials), "Peripheral Arterial Disease" (3 trials), "Pulmonary Embolism" (3 trials), "Stroke" (3 trials) and "Abdominal Aortic Aneurysm" (2 trials). Many other conditions were trialed in "Baptist Cardiac and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Baptist Cardiac and Vascular Institute" are "Device" (27 trials), "Drug" (8 trials), "Procedure" (5 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Relay Thoracic Stent-Graft" (2 trials), "0.3mm XPF cap" (1 trials), "0.5mm XPF cap" (1 trials), "Alto Abdominal Stent Graft System" (1 trials) and "Angioplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Cardiac and Vascular Institute" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Cardiac and Vascular Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Baptist Cardiac and Vascular Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Cardiac and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 21 trials that are defined as “Not Applicable".